RMD financials
ResMed (RMD) financials: revenue, profit and margins by year and quarter, the balance sheet and cash flow.
RMD income statement, yearly
| Year | Revenue | Gross profit | Operating income | Net income | EPS |
|---|---|---|---|---|---|
| 2026 | $5.65B | $3.45B | $1.91B | $1.52B | 10.40 |
| 2025 | $5.15B | $3.05B | $1.69B | $1.40B | 9.51 |
| 2024 | $4.69B | $2.66B | $1.32B | $1.02B | 6.92 |
| 2023 | $4.22B | $2.36B | $1.13B | $897.56M | 6.09 |
| 2022 | $3.58B | $2.02B | $1.00B | $779.44M | 5.30 |
| 2021 | $3.20B | $1.84B | $903.68M | $474.50M | 3.24 |
- RMD revenue was $5.65B in fiscal 2026, net income $1.52B.
Updated 2026-11-02 17:56 UTC